Bevacizumab in ovarian cancer: Clinical data and predictive and prognostic biomarkers
Evidence supporting bevacizumab in ovarian cancer and predictive biomarkers: highlighting opportunities to improve patient selection and advance personalised treatment strategies. Abstract Angiogenesis, driven by the vascular endothelial growth factor (VEGF)/VEGFR signalling axis under hypoxic conditions, is one of the hallmarks of ovarian cancer (OC),
Maria Rosaria Lamia +6 more
wiley +1 more source
Endometriosis as an immune-mediated disease: pathogenetic mechanisms and therapeutic strategies. [PDF]
Shifon S +4 more
europepmc +1 more source
Endometriosis as a Chronic Disease - Impact on Patients Quality of Life
Maciej Hobot +17 more
openalex +2 more sources
M. León +7 more
openalex +1 more source
Molecular Imaging Advances in Endometriosis: The Promise of Radiopharmaceuticals. [PDF]
Napolitano R +12 more
europepmc +1 more source
Quality of life of patients with bowel endometriosis before and after laparoscopic bowel resection
Aleksandra Vujanović +2 more
openalex +1 more source
High prevalence of progesterone receptor gene polymorphism (PROGINS) found in women with endometriosis [PDF]
Cristina Valletta de Carvalho +5 more
openalex +1 more source
ABSTRACT Background Premature ovarian insufficiency (POI) is defined as the loss of ovarian activity before age 40, resulting in hypoestrogenism, hypergonadotropic hypogonadism, amenorrhea, and infertility, significantly impacting women's reproductive and emotional health.
Farideh Pargar +4 more
wiley +1 more source
Non-Invasive Methods for Early Diagnosis of Endometriosis-A Comprehensive Narrative Literature Review. [PDF]
Gaia-Oltean AI +5 more
europepmc +1 more source

